Niche Growth: Male Fertility Supplement Market in China Hits $500M, Driven by Sperm Health Awareness

Written By camellia chen

【Abstract】: (Market Data) A new industry report by ResearchAndMarkets values the China male fertility supplement market (Zinc, CoQ10, L-Carnitine) at $500 million in 2025, with an 18% year-on-year growth rate. The driver is the rising diagnosis of "Male Factor" infertility and a cultural shift reducing stigma around male treatment.

Business Insight: Men are the new target demographic. The "She-conomy" of IVF is evolving into a "Family-conomy." Brands that package supplements as "Pre-Conception Optimization" rather than "Infertility Treatment" are seeing higher conversion rates. Exhibitors should showcase male-centric nutritional solutions at CMTF 2026.

  1. 【Keywords】: #MaleFertility #Nutraceuticals #MarketGrowth

  2. 【Source】: ResearchAndMarkets / JD Health Data (Feb 2026)

camellia chen
Previous

China Adds "Assisted Reproduction Expenses" to Individual Income Tax Special Additional Deductions
Next

Destination Marketing: South Korea Waives Visa Fees for Medical Tourists Seeking Fertility Treatment